Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

High yielding immunoglobulin manufacturing process

The invention teaches a step - charge in yielding improvement over the Cohn process, widely applicable to immunoglobulin manufacture.

Full description

The invention relates to a novel process for acheiving extraordinary high yields from any immunoglobulin manufacturing process.

To acheive this the immunoglobulin protiens are precipitated using a novel combination of agents.

Whereas the traditional Cohns cold fractionation method producres yields of around 50% or less for immunoglobulins, this new process described in the Patent Application can deliver yields of about 75-95%.

The process to achieve this is not over - complex, compromising of four steps, reasonably acheiveable by any competent fractionator.
Partnering consultation free of charge
EuroPLX 38 + 39
MipTec
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us